Croda International Plc (CRDA):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Croda International Plc (CRDA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9883
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Croda International Plc (Croda) is a chemical company, which produces and sells specialty chemicals. The company’s product portfolio includes traditional and microwave plant extracts, active ingredients and cosmetic oils among others used in coatings & polymers, crop care, geo technologies, health care, home care, industrial chemicals, lubricants, personal care and polymer additives. It offers products to various sectors including consumer care, Personal care, Life sciences and Performance technologies, Industrial chemicals. Geographically, the company’s operations are spread across France, China, Indonesia, the US, Brazil, Argentina, Sweden, Australia and South Africa among others. Croda is headquartered in Goole, East Riding of Yorkshire, the UK.

Croda International Plc (CRDA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Croda International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Croda International Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Croda International Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Croda International Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Croda International Plc, Medical Devices Deals, 2012 to YTD 2018 9
Croda International Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Croda International Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Croda International and SiSaf Enter into Agreement 11
Acquisition 12
Croda International Acquires Minority Stake in SiSaf 12
Croda International Acquires Innovachem for USD2.8 Million 13
Croda International Acquires IRB, Biotech Company 14
Croda International Plc – Key Competitors 15
Croda International Plc – Key Employees 16
Croda International Plc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Croda International Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Croda International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Croda International Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Croda International Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Croda International Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Croda International Plc, Medical Devices Deals, 2012 to YTD 2018 9
Croda International Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Croda International and SiSaf Enter into Agreement 11
Croda International Acquires Minority Stake in SiSaf 12
Croda International Acquires Innovachem for USD2.8 Million 13
Croda International Acquires IRB, Biotech Company 14
Croda International Plc, Key Competitors 15
Croda International Plc, Key Employees 16
Croda International Plc, Subsidiaries 17

List of Figures
Croda International Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Croda International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Croda International Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Croda International Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Croda International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Croda International Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Croda International Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Croda International Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Croda International Plc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Croda International Plc (CRDA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Morepen Laboratories Ltd (MOREPENLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Morepen Laboratories Ltd (Morepen Laboratories) is a manufacturer and supplier of active pharma ingredients and formulations. The company offers active pharma ingredients, formulation and homehealth solutions. It offers products in forms of tablets, capsules, liquids and powders. Morepen Lab …
  • MakeMyTrip Limited:企業のM&A・事業提携・投資動向
    MakeMyTrip Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MakeMyTrip Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Ra Medical Systems Inc (RMED):企業の製品パイプライン分析
    Summary Ra Medical Systems Inc (Ra Medical Systems) is a medical device company that develops, designs, and commercializes excimer laser systems for the treatment of cardiovascular and dermatologic diseases. The company’s technology provides operational versatility and dose customization. Its produc …
  • JSFC Sistema (AFKS):企業の財務・戦略的SWOT分析
    JSFC Sistema (AFKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Next Fifteen Communications Group plc:企業のM&A・事業提携・投資動向
    Next Fifteen Communications Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Next Fifteen Communications Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Columbus A/S (COLUM):企業の財務・戦略的SWOT分析
    Summary Columbus A/S (Columbus), formerly Columbus IT Partner A/S, is a technology company that offers integrated business systems. The company offers digital transformation, ERP and CRM solutions and Columbus solutions. Its digital transformation solution includes cloud, mobility, e-commerce and In …
  • China Merchants Securities Co Ltd (600999):企業の財務・戦略的SWOT分析
    China Merchants Securities Co Ltd (600999) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Orexigen Therapeutics Inc (OREX)-製薬・医療分野:企業M&A・提携分析
    Summary Orexigen Therapeutics Inc (Orexigen) is a biopharmaceutical company which develops and commercializes indications for the treatment of obesity. Its lead product, Contrave (naltrexone HCl / bupropion HCl prolonged release) is FDA approved as an adjunct to a reduced-calorie diet and increased …
  • Abramson Cancer Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Abramson Cancer Center (Abramson) formerly Penn Medicine's Cancer Center, a subsidiary of University of Pennsylvania is a healthcare service center that provides clinical trials for the prevention, diagnosis and treatment of cancer. The center provides supportive care services, which include …
  • Sakai Chemical Industry Co Ltd (4078):企業の財務・戦略的SWOT分析
    Sakai Chemical Industry Co Ltd (4078) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Denali Therapeutics Inc:企業のM&A・事業提携・投資動向
    Denali Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Denali Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Eguana Technologies Inc (EGT):企業の財務・戦略的SWOT分析
    Eguana Technologies Inc (EGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Westwater Resources, Inc.:企業の戦略・SWOT・財務情報
    Westwater Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Westwater Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Toronto Hydro Corporation-エネルギー分野:企業M&A・提携分析
    Summary Toronto Hydro Corporation (Toronto Hydro) is a utility holding company, providing electricity distribution and street lighting services in Toronto through its subsidiaries: Toronto Hydro-Electric System Limited (LDC) and Toronto Hydro Energy Services Inc. (TH Energy). LDC conducts electricit …
  • Genting Bhd (GENTING):電力:M&Aディール及び事業提携情報
    Summary Genting Bhd (Genting) is an investment holding and management company. The company operates through its subsidiaries in leisure, hospitality, gaming, entertainment, property development and operation, oil and gas, power generation and palm oil plantation sectors. It manages a portfolio of ho …
  • Nordex SE (NDX1):電力:M&Aディール及び事業提携情報
    Summary Nordex SE (Nordex) is an integrated supplier of onshore wind turbine systems. It develops, produces, services and markets wind power systems. The company develops and produces complete systems, including the control software and main core components, and offers related services. Nordex serve …
  • Smith & Nephew plc:企業の戦略・SWOT・財務分析
    Smith & Nephew plc - Strategy, SWOT and Corporate Finance Report Summary Smith & Nephew plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • DIA Imaging Analysis Ltd-医療機器分野:企業M&A・提携分析
    Summary DIA Imaging Analysis Ltd (DIA Imaging Analysis), formerly DiACardio Ltd is a healthcare technology company that offers medical imaging analysis software solutions. The company’s products comprise LVivo SWM, LVivo EF, and LVivo Strain. DiACardio’s LVivo SWM is a fully automated echo device or …
  • Parker Drilling Co (PKD):企業の財務・戦略的SWOT分析
    Parker Drilling Co (PKD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Nigerian National Petroleum Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Nigerian National Petroleum Corp (NNPC) is a state-owned vertically integrated oil and gas company, which explores for, produces, markets and distributes crude oil, refined petroleum, petrochemicals and associated by-products. It operates through a network of refineries that produce products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆